Product Recall: Ranitidine 150 mg & 300 mg Tablets
Post date: Nov 04, 2019 6:20:8 AM
29th October 2019 (Circular No. SP PPUM: 451/2019):
Please be informed that Pharmaniaga Manufacturing Berhad, the distributor of this product, has been given notice of product recall due to the adulterated active ingredient. The use of this product should be stopped immediately.
Therefore, all clinical areas keeping the stocks for this product are required segregate the affected stocks and send to Inpatient Pharmacy for disposal purpose. Doctors are advised to prescribe Famotidine 20 mg Tablet as alternative.